|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1940 - 0.2111|
|52 Week Range||0.1100 - 0.5450|
|Beta (5Y Monthly)||1.84|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NAPANEE, ON , May 14, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today released its first quarter 2020 financial and operating results. In April, we started planting in our airhouses in Napanee , are awaiting Health Canada approval to begin production in our Phase 5 expansion in Hope B.C. and expect to commission our new ethanol extraction suite in Napanee in Q2 2020.
Market forces rained on the parade of VIVO Cannabis Inc. (TSE:VIVO) shareholders today, when the covering analyst...
NAPANEE, ON , April 3, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") announces that it has re-purchased for cancellation certain of its outstanding 6.0% unsecured convertible debentures (each, a "Debenture"), in the aggregate principal amount of $10 million , for a purchase price of $9.3 million (plus accrued and unpaid interest thereon), representing a 7% discount to the face value, pursuant to an agreement with the holder thereof (the "Holder"). As a result of the repurchase, the Company now has Debentures in the aggregate principal amount of $24.5 million due February 28, 2021 . The Company intends to amend the debenture indenture dated February 28, 2018 to provide the remaining holders of the Debentures (other than the Holder) with a pro rata right of repurchase, at the option of each remaining holder, on the same terms as the Holder, until April 30, 2020 .
NEW YORK, NY / ACCESSWIRE / March 31, 2020 / VIVO Cannabis, Inc. (OTCMKTS:VVCIF) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 31, 2020 at 10:00 ...
NAPANEE, ON , March 30, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today released its year end and fourth quarter 2019 financial and operating results. Going forward, we see several positive catalysts which are expected to deliver profitable growth, including production expansion, distribution channel development, entry into high-growth international markets, and the development and launch of innovative products and services. The Company's gross revenue was $9.5 million for Q4 2019 and $31.8 million for 2019.
NAPANEE, ON , March 20, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced the Company, its production facilities and medical clinics are continuing to respond to COVID-19 with changes to internal business practices consistent with the guidelines of public health authorities. As VIVO continues to monitor the COVID-19 pandemic, the health and safety of its customers and employees remains the Company's top priority.
NAPANEE, ON , March 2, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is proud to congratulate the chair of its board of directors, Paul Lucas , on his receipt of the 2020 Lifetime Achievement Award from Life Sciences Ontario. This award is in recognition of Mr. Lucas' exceptional leadership and contributions to the development of the life sciences sector in Canada , his commitment to the community and his passion for improving the quality of life for Canadians. Mr. Lucas is a highly respected leader in the Canadian pharmaceutical and life science industries.
NAPANEE, ON , Jan. 23, 2020 /CNW/ - VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce its common shares (the "Common Shares") will begin trading on the Toronto Stock Exchange (the "TSX") effective as of market open on January 24, 2020 , under the current trading symbol of VIVO. In conjunction with the TSX listing, the Common Shares will be voluntarily delisted from the TSX Venture Exchange.
NAPANEE, ON , Dec. 20, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today officially revealed its new Cannabis 2.0. VIVO will focus on the vape, chocolates and concentrates categories leveraging VIVO's premium adult-use cannabis brands including Canna Farms™ and Fireside™. The range of new products includes Canna Farms™ BC Kief, Canna Farms™ BC Bubble Hash, Canna Farms™ BC Live Rosin, and Canna Farms™ BC Hash Rosin.
Received conditional approval to graduate from the TSX Venture Exchange (the "TSXV") and list common shares on the Toronto Stock Exchange (the "TSX"). Completed first harvest at the new 86,000 square foot Kimmetts airhouse facility in Napanee, Ontario , following the issuance of a standard cultivation licence by Health Canada in August 2019 . Received a licence amendment to begin selling cannabis edibles, concentrates and topicals, with sales of premium cannabis chocolates, bubble hash, rosin, shatter, wax, vape pens and cartridges expected to commence in Ontario and other Canadian markets later this year or early in 2020.
NAPANEE, ON , Nov. 12, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange (the "TSXV") and list its common shares on the TSX.
CB2 Insights (CSE: CBII) (OTCQB: CBIIF) has agreed to assist VIVO Cannabis (TSX-V: VIVO) (OTCQX: VVCIF) in the development of VIVO's global medical product development strategy. Under a technology and multi-phase research agreement, CB2 will be integrating its Clinical Data Management Software (CDMS) and Electronic Data Capture (EDC) tools to establish a better understanding of VIVO's current […]The post VIVO Partners CB2 Insights to Create Global Cannabis Product Strategy appeared first on Market Exclusive.
OTCQB: CBIIF) ("CB2"), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, announced it has entered into a technology and multi-phase research agreement with VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO"), an Ontario -based cannabis company recognized for its premium products and services, to assist in the development of VIVO's global medical product development strategy. Under the terms of the agreement, CB2 will be integrating CB2's Clinical Data Management Software (CDMS) and Electronic Data Capture (EDC) tools to establish better understanding of VIVO's current medical patient registry.
NAPANEE, ON , Oct. 3, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced it expects to commence first harvest at its Kimmetts facility in Napanee, Ontario in the fourth quarter of 2019. VIVO also unveiled its 2020 plans for the facility, which include an accelerated planting schedule and the contemplated use of five additional acres of land adjacent to the existing airhouses. The announcements were made during VIVO's analyst and investor day held in Napanee , where the Company showcased its airhouse technology, extraction programs and progress towards achieving EU GMP certification.
NAPANEE, ON , Sept. 17, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced it has partnered with Linneo Health S.L. ("Linneo Health"), a subsidiary of Alcaliber S.A., to be its European medical cannabis supply partner. Linneo Health, a European leader in the pharmaceutical cannabis industry, recently received its EU-GMP (Good Manufacturing Practices) certification from the Spanish regulatory authorities. "Our partnership with Linneo Health is part of our strategic priority to accelerate international market growth," said Barry Fishman , Chief Executive Officer of VIVO.
Canopy Rivers (TSXV: RIV) (OTC: CNPOF) announced that its portfolio company TerrAscend (CSE: TER) (OTCQX: TRSSF) has signed agreements to acquire ABI SF, which operates a Bay Area cannabis cultivation facility and owns the State Flower brand. State Flower is known for its ultra-premium cannabis flower and is currently sold through dispensaries in California and Nevada. Vapen […]The post Cannabis Stock News Daily Roundup August 30 appeared first on Market Exclusive.
Health Canada approval was received to begin extraction operations using VIVO's on-site CO2 extraction system at the Napanee facility, and the Company has procured an ethanol system that will bring total extraction capacity to 50,000 kilograms per year. NAPANEE, ON , Aug. 28, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), today released its second quarter 2019 financial and operating results. "We remain focused on increasing long-term shareholder value by continuing to establish ourselves as a premium provider of cannabis products and services.
NAPANEE, ON , Aug. 6, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, ABcann Medicinals Inc., has been granted a Standard Cultivation licence from Health Canada for its Kimmetts facility. Kimmetts, an innovative seasonal greenhouse site in Napanee, Ontario , is VIVO's third licensed production facility. The new site will increase the Company's annualized cultivation capacity by 4,000 kilograms, bringing its total internal licensed capacity to over 12,000 kilograms.
"We are extremely excited to commence CO2 extraction operations at our Napanee facility," said Gary McMullen , Vice-President, Napanee Operations. Upon receipt of EU-GMP certification for its Napanee facility, the Company is expected to be able to ship extracted cannabis products to Europe and other countries for scientific and medical purposes, subject to receipt of all necessary import and export permits, in addition to selling domestically.
VIVO Cannabis (TSX-V: VIVO) (OTCQX: VVCIF) has announced that it has made a C$1.25 million investment in Friendly Stranger Holdings, Canada's most iconic cannabis culture shop. The investment will facilitate Friendly Stranger's aggressive cannabis retail expansion plans, with a goal of bringing multiple retail stores to the Canadian market, VIVO said in a statement. "VIVO is […]The post VIVO Bullish on Cannabis Retailer Friendly Stranger appeared first on Market Exclusive.